Hsinchu – September 22, 2026 -- ICP DAS will demonstrate its iTLC-9000 Series Redundant Multifunctional Traffic Signal Control System at APTA 2026 TRANSform & EXPO, running October 4–7 at McCormick Place in Chicago, Illinois. The company will occupy Booth 4625, running a live simulated intersection where the iTLC-9000 operates two actual sets of traffic signals in real time.
Hangzhou, China – September 21, 2026 -- A joint survey by asmag.com and Hikvision found that 38.2% of video security professionals call storage cost or capacity a "major challenge," while another 43.2% rate it "moderate," together accounting for 81.4% of respondents.
Asked how the storage challenge has changed compared with a year earlier, 43.2% of respondents said pressure has "increased moderately," pointing to persistent upward cost trends across video security deployments rather than a one-time spike.
Jinan – September 21, 2026 -- Bestzyme, a synthetic biology unit of GenScript Biotech, has completed what it calls the world's first dedicated, automated smart production line for sweet proteins at its Jinan facility, integrating R&D, mass production and application for the ingredient category for the first time globally.
The 5,000-square-meter plant runs a fully automated fermentation-purification-freeze-drying process for Bestzyme's flagship Mellia® Brazzein sweet protein. Once operational, the line will produce over 100 tons annually, a volume the company says matches the sweetness output of 300,000 tons of sucrose. Bestzyme expects capacity to potentially double within two years.
Dallas – September 21, 2026 -- AI Hospitality Group (AIHG) launched with $7.5 million in seed funding and a pledge to deliver more than 500 basis points of gross operating profit margin improvement to hotel owners through a fully AI-native management model. The company, founded by former Remington Hospitality CEO Sloan Dean, signs hotel management agreements directly with owners and takes responsibility for the P&L rather than licensing software to existing operators.
AIHG says U.S. hotel EBITDA margins have fallen approximately 20% since 2019, while CMBS delinquency rates for limited-service hotels hit 8.35% in July 2025, more than double their 2022 low. The company cites 65% of North American hotels reporting staffing shortages in 2025, with labor costs rising 11.2% year over year.
Seattle – September 21, 2026 -- Sudheer Koneru, CEO and founder of Zenoti, unveiled a new book, Growth Diaries: How the Best Beauty and Wellness Brands Scale from 1 Store to 100+, drawing on interviews with 42 founders, CEOs, and industry leaders across nine countries.
Growth Diaries organizes the operators' experiences into four stages: the first store, the early chain, infrastructure, and institutional scale, providing a stage-by-stage framework for founders scaling service-based businesses. The book argues that beauty, wellness, and fitness brands face distinct scaling challenges compared to software, retail, or restaurant companies, since services are delivered live and an unfilled appointment cannot be recovered as revenue later.
Taipei – September 21, 2026 -- Merry Life Biomedical has advanced TML-6, a Taiwan-developed oral therapy for early Alzheimer's disease, into a global Phase 2 trial spanning 20 clinical sites across Taiwan, Sweden, and the United States, targeting approximately 210 participants.
The study includes nine medical centers in Taiwan, seven sites in Sweden, and four centers in the United States, with Taiwan forming the largest single group of participating sites. The randomized, double-blind, placebo-controlled trial will assign patients to TML-6 100 mg, TML-6 200 mg, or placebo, administered once daily for 52 weeks.
Elmhurst, N.Y. – September 21, 2026 -- Century Fasteners Corp. will exhibit at the 2026 International Fastener Expo in Phoenix, Arizona, from October 7-9, presenting its authorized distributor relationship with Cherry Aerospace at Booth 2756.
Century Fasteners Corp., an authorized distributor for Cherry Aerospace, said the partnership broadens availability of Cherry's fastening systems to distributors and OEMs. Cherry Aerospace, headquartered in Santa Ana, California, is a member of the SPS Fastener Division of Precision Castparts Corp. and manufactures the CherryMax line of rivets, widely used across the aerospace industry alongside blind bolts, rivetless nut plates, shear pin fasteners and installation tools.
West Chester, Ohio – September 21, 2026 -- Upside Innovations, a SixAxis company, has launched FlowRail, a patent-pending prefabricated aluminum guardrail system that adjusts continuously in the field across slopes, curves, corners and grade changes without custom fabrication or on-site welding.
FlowRail's continuously adjustable base moves from 0° to 20°, keeping posts plumb on ramps, walkways or platforms. Pivoting connections follow curves, corners and switchbacks without splice castings or custom fittings, allowing a single product line to cover an entire installation run.
Phoenix – September 21, 2026 -- Cosign, a third-party guarantor platform and cosigner alternative, has launched in the Phoenix-Mesa-Chandler metro area as apartment vacancy in the region holds near a post-Great Recession high of 10.8%, according to CoStar data cited by the company.
Maricopa County and the broader Phoenix-Mesa-Chandler MSA rank among the nation's top 10 highest-vacancy markets, alongside Sun Belt peers Austin, Charlotte and San Antonio. Asking rents in the metro fell 1.2% over the past year, and operators are increasingly turning to concessions, with 10 or more weeks of free rent now common at newly built communities.
Houston – – September 21, 2026 -- Eli Lilly and Company (NYSE: LLY) has broken ground on a $6.5 billion manufacturing site in Houston, Texas, that will produce active pharmaceutical ingredients for Foundayo (orforglipron), the company's first synthetic oral GLP-1 medicine for weight management.
The plant is one of ten U.S. manufacturing sites Lilly has announced since 2020 and the fifth dedicated to producing active pharmaceutical ingredients domestically. The investment falls under Lilly's broader $50 billion initiative to reshore medicine production in the United States and export American-made drugs globally.